Results 241 to 250 of about 265,739 (284)

Aldehyde-Functionalized Cellulose Nanofiber Hydrogels for pH-Sensitive Drug Delivery via Dynamic Imine Bonding. [PDF]

open access: yesACS Omega
Tsubota H   +10 more
europepmc   +1 more source

Simultaneous Cross-Linking and Nanoparticle Anchoring by Dialdehyde Cellulose in Injectable Composite Chitosan/Polypyrrole Hydrogels. [PDF]

open access: yesACS Appl Bio Mater
Muchová M   +6 more
europepmc   +1 more source

Conventional Versus Accelerated Collagen Cross-Linking for Keratoconus

Eye & Contact Lens: Science & Clinical Practice, 2015
: Collagen cross-linking (CXL) is a procedure that primarily aims to increase corneal stiffness. Although used for a variety of conditions, it is most commonly applied to the treatment of keratoconus. Collagen cross-linking involves irradiation of the cornea with ultraviolet A (UVA) irradiation after it has been soaked with riboflavin (vitamin B), a ...
Aris, Konstantopoulos, Jodhbir S, Mehta
openaire   +2 more sources

Accelerated corneal collagen cross-linking for progressive keratoconus

Cutaneous and Ocular Toxicology, 2013
To evaluate the efficacy of accelerated corneal cross-linking (CXL) procedure for progressive keratoconus.Twenty-three eyes of 23 patients undergone accelerated CXL procedure were evaluated preoperatively and postoperatively at 1st, 3rd and 6th month for uncorrected distant visual acuity (UDVA), best corrected distant visual acuity (CDVA), spherical ...
Yasin, Cınar   +7 more
openaire   +2 more sources

Scotopic contrast sensitivity and glare after accelerated corneal cross‐linking [PDF]

open access: yesAustralasian journal of optometry, The, 2018
The aim was to assess one-year changes in uncorrected and corrected contrast sensitivity (CS) and glare under scotopic conditions after accelerated cross-linking (CXL) using the 18 mW/cm2 protocol for the treatment of progressive keratoconus and compare results with unoperated controls.In this non-randomised clinical trial, 30 eyes were enrolled in the
Soheila Asgari   +2 more
exaly   +3 more sources

Home - About - Disclaimer - Privacy